Michelle Seywald
Venture Analyst at Apollo Health Ventures
📍 London, England, United Kingdom
Michelle Seywald is a Venture Analyst at Apollo Health Ventures, focusing on longevity and aging biotechnology. Her background includes engineering roles at Edwards Lifesciences and Stryker. She holds a prestigious MS/MBA dual degree in Biotechnology from Harvard, equipping her to bridge scientific innovation with business strategy.
Her dual degree from Harvard was specifically chosen to learn the business skills necessary to translate scientific discoveries into therapies that improve patients’ lives.
Read the full overview →Experience
10 Years
Current Role
Venture Analyst
Job Level
Middle
Location
London, England, United Kingdom
Personality Overview
Personality insights not availableWe need more social data to generate the DISC analysis and selling playbook. The professional details below are still available.
Priorities
Topics Michelle cares about
Longevity Investing
As a Venture Analyst at Apollo Health Ventures, her primary focus is on aging and longevity biotechnology investments.
Biotech Commercialization
Pursued a dual MS/MBA from Harvard to learn how to translate scientific discoveries into viable patient therapies.
Career
Work history
3-2025
Venture Analyst
Apollo Health Ventures
9-2024 - 3-2025
Venture Labs Fellow
Apollo Health Ventures
7-2022 - 9-2024
MS/MBA Biotechnology: Life Sciences
Harvard Business School
11-2019 - 4-2022
Clinical Development Engineer II
Edwards Lifesciences
9-2017 - 5-2019
Post-Market Design Engineer
Stryker
In the press
Media appearances
No media yetWe could not find public media appearances for this person.
Education
7-2022 - 5-2024
MS/MBA Biotechnology Dual Degree
Harvard Business School
7-2022 - 5-2024
Master of Science - MS
Harvard Kenneth C. Griffin Graduate School of Arts and Sciences
Social presence
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.